Question 1

What routes can Letermovir be administered by?

Accepted Answer

Available routes: PO, IV.

Question 2

Is Letermovir a controlled substance?

Accepted Answer

Letermovir is not federally scheduled in the US. Controlled-drug status differs by country — verify your local rules.

Question 3

What are the warnings or contraindications for Letermovir?

Accepted Answer

CYP3A4 interactions (especially with cyclosporine). GI upset. CMV-specific — no broad-spectrum activity. No veterinary data.

Question 4

What are the side effects of Letermovir?

Accepted Answer

Reported side effects, adverse reactions, and contraindications for Letermovir: CYP3A4 interactions (especially with cyclosporine). GI upset. CMV-specific — no broad-spectrum activity. No veterinary data.

Question 5

How does Letermovir work?

Accepted Answer

Inhibits the CMV DNA terminase complex (pUL56), blocking viral DNA cleavage and packaging. Novel non-nucleoside mechanism.

Letermovir

Drug Class

Routes

Mechanism of Action

Side effects & warnings

Upgrade for Full Details